Secretion of luteinizing hormone is decreased when hens start to incubate their eggs and is increased after nest deprivation or hatching of the eggs. The purpose of this study was to determine whether decreased luteinizing hormone (LH) secretion during incubation in the domestic hen is associated with a decrease in hypothalamic chicken gonadotropin-releasing hormone-I (cGnRH-I) mRNA or peptide. A semiquantitative competitive PCR assay was developed to measure cGnRH-I mRNA. Hypothalamic mRNA was quantified as the amount of GnRH cDNA obtained by reverse transcription of cGnRH-I mRNA. The amount of hypothalamic cGnRH-I mRNA was significantly higher in laying than in incubating hens (38.7 ± 10.3 vs. 7.7 ± 1.6 × 10–17 mol cDNA, p = 0.01, n = 8). The hypothalamic GnRH peptide content was not significantly different between laying and incubating hens in either the preoptic area (286.9 ± 24.01 vs. 269.3 ± 29.3 pg, n = 8) or the basal hypothalamus (1.67 ± 0.19 vs. 1.54 ± 0.21 ng, n = 8). Five days after incubating hens were deprived of their eggs, the resulting increase in LH secretion was associated with a significant increase in hypothalamic content of cGnRH-I mRNA (22.8 ± 2.2 vs. 6.7 ± 1.7 × 10–17 mol cDNAp < 0.001, n = 8). These observations suggest that a decrease in the expression of the cGnRH-I gene is a major factor in maintaining depressed LH secretion in incubating domestic chickens.

Keywords:
Gonadotropin-releasing hormone, Chicken, Polymerase chain reaction, Prolactin
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.